Workflow
以费换量
icon
Search documents
营收增长与净利大幅背离,丸美生物被费用“绊住了脚”丨看财报
Tai Mei Ti A P P· 2025-08-25 00:36
Core Viewpoint - Marubi Biological achieved a revenue growth of 30.83% year-on-year, contrasting with a mere 5.21% increase in net profit, indicating a structural adjustment in the beauty industry where the company is prioritizing online direct sales over profitability [2][7]. Revenue Performance - In the first half of the year, Marubi Biological reported a revenue of 1.769 billion yuan, up from 1.352 billion yuan in the same period last year, marking a significant acceleration in growth [2][4]. - The overall cosmetics retail sales in China grew by only 2.9%, significantly lower than the 5% increase in total retail sales, highlighting Marubi's outperformance in a sluggish market [2]. Brand Strategy - The main brand Marubi continues to strengthen its position in eye care, while the new makeup brand Lianhuo focuses on foundation products, contributing to a diversified product matrix [4]. - Marubi's core products, such as the peptide eye cream and collagen essence, have driven substantial revenue, with the new collagen mask achieving top sales on Tmall [4]. Channel Performance - Online sales accounted for 89% of total revenue, growing by 37.9%, while offline sales declined by 7.1%, indicating a strong shift towards online channels [6]. - Tmall serves as the primary online platform for Marubi, with top products accounting for 73% of sales, and membership transactions increasing by 28% [6]. Profitability Challenges - The company's net profit for the first half was 186 million yuan, a modest increase of 5.21%, with a significant drop in net profit in the second quarter [7][8]. - Sales expenses surged to 1 billion yuan, with a sales expense ratio of 56.53%, far exceeding competitors, driven by high marketing costs [8][10]. Marketing and Cost Structure - Advertising expenses reached 905 million yuan, a 42.97% increase from the previous year, contributing to the disparity between revenue growth and profit [10][12]. - The overall gross margin slightly decreased to 74.6%, with a more pronounced decline in the second quarter, indicating pressure on profit margins due to pricing strategies and cost structures [10][12]. Industry Context - The trend of "spending to gain volume" is prevalent in the beauty industry, where companies must continuously invest in marketing to avoid revenue stagnation [12].
“禁酒令”冲击市场,名酒以费换量
Sou Hu Cai Jing· 2025-08-03 02:38
自去年起,众多酒类企业纷纷采取了谨慎的经营策略,而在2025上半年,茅台、五粮液等品牌酒企还采取了诸如暂停供货等市场手段,以实现对价格的稳 定。 但是随着"最严禁酒令"带来的影响持续,为应对市场销量的下滑,不少名酒企业纷纷选择增加渠道费用投放以刺激动销。 以开头的某浓香名酒为例,根据其最新的扫码活动政策,其扫码红包的奖项级别为30元的五等奖、100元的四等奖、200元的三等奖、500元的二等奖、 2000元的一等奖和2万元的特等奖。 文 | 岳治中 随着"禁酒令"带来的经营压力,已经有相当部分名酒选择用利润换销量。 近日,微酒从渠道获悉,某浓香名酒在近期召开的经销商联谊会半年工作会议上向经销商透露,下半年将加大经销商和终端的开瓶扫码激励力度。 事实上,加大开瓶扫码激励力度只是当前名酒用利润换销量的举措之一。据微酒了解,目前已有多家名酒企业开始调整渠道策略,不仅增加固定费用投 放,对特定消费场景还有额外激励支持。 从控价保量到以费换量,名酒营销动作调整的背后有着哪些原因?又将给产业带来怎样的影响? 价格始终是白酒产业链中的"晴雨表"和"调节器",特别是在当前的深度调整阶段,稳定价格和清理库存成为了连接生产、分销 ...